Definium Therapeutics News - June 26, 2026

DFTX

🔴 DFTX is trading 4.1% down today after closing an upsized $805M equity offering

DFTX is trading at $42.95 (4.1% down) as investors digest the impact of a large, upsized equity raise following its recent clinical rally. • The company...
Definium Therapeutics Secures $758 Million, Advancing Late-Stage Psychiatric Pipeline
DFTX

Definium Therapeutics Secures $758 Million, Advancing Late-Stage Psychiatric Pipeline

Definium Therapeutics, Inc. closed its underwritten public offering of 20,588,236 common shares. The shares were priced at $34.00 per share. The offering was...